Supply Of 1) LIGNOCAINE 2% + ADRENALINE INJ 30 ML VIAL, 2) LIGNOCAINE 4 % TOPICAL SOLUTION 30 ML VIAL, 3) LIGNOCAINE 2% JELLY 30 G TUBE, 4) LIGNOCAINE INJ 2 % 30 ML VIAL, 5) LIGNOCAINE 2% INTRAVENOUS 50 ML VIAL, 6) LIGNOCAINE TOPICAL AEROSOL 10 % SPR
Tender Overview
Project Description
Supply Of 1) lignocaine 2% + adrenaline inj 30 ml vial, 2) lignocaine 4 % topical solution 30 ml vial, 3) lignocaine 2% jelly 30 g tube, 4) lignocaine inj 2 % 30 ml vial, 5) lignocaine 2% intravenous 50 ml vial, 6) lignocaine topical aerosol 10 % spray minimum 50 ml & 7) lidocaine 2.5% + prilocaine 2.5% ceram 30 g tube , srphc82011110-lignocaine inj 2 % 30 ml vial [quantity tolerance (+/-): 5 %age , item category : normal , total po value variation permitted: max 8 la cs ] ] , srphc82011055-lignocaine 2% + adrenaline inj 30 ml vial [quantity tolerance (+/-): 5 %age , item category : normal , total po value variation permitted: max 8 la cs ] ] , srphc82011105-lignocaine 2% jelly 30 g tube unit:tube [quantity tolerance (+/-): 5 %age , item category : normal , total po value variation permitted: max 8 la cs ] ] , srphc82011115-lignocaine 2% intravenous 50 ml vial [quantity tolerance (+/-): 5 %age , item category : normal , total po value variation permitted: max 8 la cs ] ] , srphc82011085-lignocaine 4 % topical solution 30 ml vial [quantity tolerance (+/-): 5 %age , item category : normal , total po value variation permitted: max 8 la cs ] ] , srphc82013016-lignocaine topical aerosol 10 % spray minimum 50ml [quantity tolerance (+/-): 5 %age , item category : normal , total po value variation permitted: max 8 la cs ] ] , srphc82013030-lidocaine 2.5% + prilocaine 2.5% ceram 30 g tube unit:tube [quantity tolerance (+/-): 5 %age , item category : normal , total po value variation permitted: max 8 la cs ] ]
BOQ
| Sl. No. | Item Description |
|---|---|
| 1 | SRPHC82011110-LIGNOCAINE INJ 2 % 30 ML VIAL [Quantity Tolerance (+/-): 5 %age , Item Category : Normal , Total PO value variation Permitted: Max 8 la cs ] ] |
| 2 | SRPHC82011055-LIGNOCAINE 2% + ADRENALINE INJ 30 ML VIAL [Quantity Tolerance (+/-): 5 %age , Item Category : Normal , Total PO value variation Permitted: Max 8 la cs ] ] |
| 3 | SRPHC82011105-LIGNOCAINE 2% JELLY 30 G TUBE UNIT:TUBE [Quantity Tolerance (+/-): 5 %age , Item Category : Normal , Total PO value variation Permitted: Max 8 la cs ] ] |
| 4 | SRPHC82011115-LIGNOCAINE 2% INTRAVENOUS 50 ML VIAL [Quantity Tolerance (+/-): 5 %age , Item Category : Normal , Total PO value variation Permitted: Max 8 la cs ] ] |
| 5 | SRPHC82011085-LIGNOCAINE 4 % TOPICAL SOLUTION 30 ML VIAL [Quantity Tolerance (+/-): 5 %age , Item Category : Normal , Total PO value variation Permitted: Max 8 la cs ] ] |
| 6 | SRPHC82013016-LIGNOCAINE TOPICAL AEROSOL 10 % SPRAY MINIMUM 50ML [Quantity Tolerance (+/-): 5 %age , Item Category : Normal , Total PO value variation Permitted: Max 8 la cs ] ] |
| 7 | SRPHC82013030-LIDOCAINE 2.5% + PRILOCAINE 2.5% CERAM 30 G TUBE UNIT:TUBE [Quantity Tolerance (+/-): 5 %age , Item Category : Normal , Total PO value variation Permitted: Max 8 la cs ] ] |
AI Tender Summary
Tender Timeline
Tender Published
Tender notice published.
CompletedBid Submission Deadline
Online submission via eProcurement portal.
Upcoming · 13 daysTender Documents
Download All (ZIP) ↓We takes all possible care for accurate & authentic tender information. However users are requested to refer Original source of Tender Notice / Tender Document published by Tender Issuing Agency before taking any call regarding this tender